ANI Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Highlights Operational Strength NFGC Q1 2026 Earnings Deep EPS Miss Underscores PreRevenue Stage Challenges MCRB Q1 2026 Earnings EPS Misses Estimates Stock Declines 417 EQX Q1 2026 Earnings Marginal EPS Miss as Stock Declines CPAY Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance Magyar Bancorp Inc MGYR Q4 2025 Earnings EPS of 040 Achieved Stock Unchanged